Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
Cash to Debt Ratio
4.15 (As of Jun. 2013)

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash and cash equivalents divide by its debt. Onyx Pharmaceuticals, Inc.'s cash to debt ratio for the quarter that ended in Jun. 2013 was 4.15.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Onyx Pharmaceuticals, Inc. could pay off its debt using the cash in hand for the quarter that ended in Jun. 2013.

ONXX' s 10-Year Cash to Debt Range
Min: 0   Max: 0
Current: 0

ONXX's Cash to Debtis ranked lower than
65% of the 1248 Companies
in the Global Biotechnology industry.

( Industry Median: 67.35 vs. ONXX: 0.00 )

Definition

This is the ratio of a company's Cash and cash equivalents to its debt. The debt includes the Current Portion of Long-Term Debt and Long-Term Debt. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Onyx Pharmaceuticals, Inc.'s Cash to Debt Ratio for the fiscal year that ended in Dec. 2012 is calculated as:

Cash to Debt Ratio=Cash and Cash Equivalents / Total Debt
=Cash and Cash Equivalents / (Short-Term Debt + Long-Term Debt)
=484.436 / (0 + 174.404)
=2.78

Onyx Pharmaceuticals, Inc.'s Cash to Debt Ratio for the quarter that ended in Jun. 2013 is calculated as:

Cash to Debt Ratio=Cash and Cash Equivalents / Total Debt
=Cash and Cash Equivalents / (Short-Term Debt + Long-Term Debt)
=750.456 / (0 + 180.7)
=4.15

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Related Terms

Current Portion of Long-Term Debt, Long-Term Debt, Cash and Cash Equivalents (For Banks and Insurance Companies), Cash and Cash Equivalents


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

Dec03Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12
cash2debt No DebtNo DebtNo DebtNo DebtNo DebtNo Debt3.833.603.972.78

Onyx Pharmaceuticals, Inc. Quarterly Data

Mar11Jun11Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13
cash2debt 3.443.323.163.973.623.393.242.784.124.15
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK